SGLT2 inhibitors, GLP-1 RAs, and DPP4 inhibitors and the risk of hypomagnesemia in type 2 diabetes: A target trial emulation.
Saved in:
| Title: | SGLT2 inhibitors, GLP-1 RAs, and DPP4 inhibitors and the risk of hypomagnesemia in type 2 diabetes: A target trial emulation. |
|---|---|
| Authors: | Shao, Shih-Chieh1,2,3 (AUTHOR), Tsai, Daniel Hsiang-Te2,3 (AUTHOR), Chuang, Albert Tzu-Ming2,3 (AUTHOR), Liu, Kuan-Hung4,5 (AUTHOR) kh_liu@gs.ncku.edu.tw, Lai, Edward Chia-Cheng2,3 (AUTHOR) |
| Source: | PLoS Medicine. 3/6/2026, Vol. 23 Issue 3, p1-18. 18p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 15491277 |
|---|---|
| DOI: | 10.1371/journal.pmed.1004968 |
